Softwr

Research · head to head

Greenphire vs Labguru

Greenphire logo

Greenphire

Research

Clinical trial participant payments, reimbursement and travel, now part of Suvoda

From
On request
Rated
-
Full reviewWebsite
Labguru logo

Labguru

Research

Electronic lab notebook, LIMS and inventory in one system, now sold under the Cenevo group

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Greenphire the standalone greenphire.com site now redirects to Suvoda and the brands have been integrated, so buyers are contracting with a randomisation and supply vendor and should expect cross selling rather than an independent payments specialist.; Labguru ownership changed twice in short order, to Battery Ventures in 2024 and then into the Cenevo brand with Titian Software in 2025, so the medium-term roadmap is a group strategy decision rather than a product one and buyers should ask directly what happens to the notebook.
  • They diverge on capability: Greenphire covers ClinCard, Labguru covers Combined ELN and LIMS.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Greenphire and Labguru actually diverge.

Attributes where Greenphire and Labguru differ
AttributeGreenphireLabguru
PlatformsWeb, iOS, AndroidWeb, iOS, Android, On-premise

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Greenphire

  • ClinCard
  • Direct to bank payment
  • Expense reimbursement
  • Travel and logistics
  • Site payments
  • Budgeting and benchmarking
  • Tax handling

Only in Labguru

  • Combined ELN and LIMS
  • Validated cloud hosting
  • Inventory and stock
  • Chemistry module
  • Equipment management
  • Electronic batch records
  • Label Wizard
  • API and developer tools

What people use each for

The jobs each tool is most often brought in to do.

Greenphire

  • A global Phase III trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payablenot Labguru
  • A decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodationnot Labguru
  • A trial in a population where slow reimbursement drives dropout and same day payment materially helps retentionnot Labguru
  • A sponsor that wants site payment milestones and participant payments handled by one vendor rather than twonot Labguru

Labguru

  • A biotech that wants experiment records and sample inventory in one system instead of paying for an ELN and a LIMS separatelynot Greenphire
  • A chemistry group needing structure registration attached to the experiment rather than in a standalone databasenot Greenphire
  • A contract research organisation that must show sample traceability from receipt to reported result during a client auditnot Greenphire
  • An academic institute standardising dozens of small labs off shared spreadsheets and paper notebooks onto one searchable recordnot Greenphire

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Greenphire

  • The standalone greenphire.com site now redirects to Suvoda and the brands have been integrated, so buyers are contracting with a randomisation and supply vendor and should expect cross selling rather than an independent payments specialist.
  • Nothing is published on price, and the typical shape of a platform fee plus per participant and per transaction charges means the cost of a trial is not knowable until enrolment is known.
  • Payment method availability varies sharply by country, so a global protocol may end up with card payments in some regions and slow manual processes in others, which undermines the retention argument that justified the purchase.
  • Sites bear the administrative work of enrolling participants and triggering payments but are not the buyer, so adoption depends on the sponsor mandating it and site resistance is a real implementation risk.
  • Participant payments create tax reporting obligations that differ per jurisdiction, and the tooling helps but does not remove sponsor liability, so legal and finance review is required in every country the trial runs in.

Labguru

  • Ownership changed twice in short order, to Battery Ventures in 2024 and then into the Cenevo brand with Titian Software in 2025, so the medium-term roadmap is a group strategy decision rather than a product one and buyers should ask directly what happens to the notebook.
  • The validated GxP hosting option is a separate commercial line, not a configuration setting, so a lab that discovers mid-project that it needs a validated instance faces a new contract and a new price rather than an upgrade.
  • Being both an ELN and a LIMS means it is shallower than dedicated tools in each role; high-throughput sample management and deep bioinformatics workflows both hit limits that a specialist would not.
  • No pricing is published at all, and modules such as chemistry, batch records and equipment are quoted on top, so the real annual figure only appears after a sales process.
  • Validation, SOPs and periodic revalidation after vendor releases are the customer obligation on a regulated instance, and cloud release cadence means that revalidation is a recurring internal cost that never appears on the vendor quote.

Pricing, plan by plan

Greenphire

On request
  • Greenphire Patient Payments$undefined/year
    • Priced per study through a sales process
    • Typically a platform fee plus per participant and per transaction charges
    • Funding of the payment float is separate from the software fee

Labguru

On request
  • Labguru$undefined/year
    • Priced per user per year on quotation with volume tiers
    • ELN, LIMS and inventory in the base platform
    • Chemistry, batch records and equipment modules quoted separately

Which should you pick?

Choose Greenphire if

  • You need clincard.
  • You work on Web, iOS, Android.
  • You also want direct to bank payment.
Greenphire review

Choose Labguru if

  • You need combined eln and lims.
  • You work on Web, iOS, Android, On-premise.
  • You also want validated cloud hosting.
Labguru review

Questions people ask

Is Greenphire or Labguru better?
Neither clearly leads. Greenphire starts at On request and Labguru at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Greenphire or Labguru?
Greenphire starts at On request and Labguru at On request.
Does Greenphire or Labguru run on more platforms?
Greenphire runs on Web, iOS, Android. Labguru runs on Web, iOS, Android, On-premise.
What is Greenphire best used for?
Greenphire is most often used for a global phase iii trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payable, a decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodation, a trial in a population where slow reimbursement drives dropout and same day payment materially helps retention, a sponsor that wants site payment milestones and participant payments handled by one vendor rather than two. Of those, a global phase iii trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payable and a decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodation are not what Labguru is typically brought in for.
What can Greenphire do that Labguru cannot?
Greenphire covers ClinCard, Direct to bank payment, Expense reimbursement, Travel and logistics. Labguru covers Combined ELN and LIMS, Validated cloud hosting, Inventory and stock, Chemistry module.

Answered from the vendors’ own pages

Greenphire: Is Greenphire still sold?

Yes, as Greenphire Patient Payments on the Suvoda platform. The independent website and social presence have been consolidated into Suvoda.

Labguru: Who owns Labguru now?

Battery Ventures acquired it in April 2024. Since July 2025 it operates under the Cenevo brand following a merger with Titian Software.

Greenphire: What is ClinCard?

The reloadable debit card Greenphire issues to participants. Greenphire Patient Payments was formerly known as ClinCard.

Labguru: Is it an ELN or a LIMS?

Both, in one product. That is the main reason labs choose it, and also why it is shallower than a specialist in each role.

Greenphire: Does it publish pricing?

No. Pricing is per study and quoted through sales, and funding the payments themselves is separate from the software fee.

Labguru: Does it support GxP work?

Yes, through a separately contracted validated cloud instance. Validation for your intended use remains your responsibility.

Greenphire: Can it pay participants outside the United States?

Yes, in more than thirty currencies, but the available payment method depends on the country.

Labguru: Is pricing published?

No. It is quoted per user per year, with modules and validated hosting priced on top.

Share

Related pages

More on Greenphire

More on Labguru

Keep looking

Other head to heads